JENILEE POWELL: Open Payments
NPI 1700598331 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$480 in 24 payments from 11 companies in 2025. Trend: 2023 $29 · 2024 $618 · 2025 $480
Food & beverage: $480
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 6 | $134 |
| Corium, LLC | 4 | $73 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Lilly USA, LLC | 2 | $46 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Novo Nordisk Inc | 2 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| ABBVIE INC. | 1 | $25 |
| Exact Sciences Corporation | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: XYWAV, Azstarys, FARXIGA, MOUNJARO, TRELEGY ELLIPTA, Ozempic, Kerendia, QULIPTA.
Industry payments across AL — which companies pay providers there.
